Max Planck Institute for Molecular Biomedicine
The Max Planck Institute for Molecular Biomedicine was founded on 1 April 2001 in Münster, North Rhine-Westphalia, Germany. It is part of the Max Planck Society. The current managing director is Prof. Sara Wickström. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Max Planck Institute for Molecular Biomedicine, Germany, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
76%
Total
Publications
1.4K
Total Open
Publications
1.1K
Total
Citations
89K
Open Access
Percentage
76%
Total
Publications
1.4K
Total Open
Publications
1.1K
Total
Citations
89K
Breakdown
Publisher Open
21%
Both
45%
Other Platform Open
10%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
339
Hybrid 33%
295
No Guarantees 30%
275
Other Platform Open
Domain 83%
637
Institution 28%
212
Preprint 16%
121
Public 11%
86
Other Internet 10%
79
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 636 |
Europe PMC | Domain | 370 |
bioRxiv | Preprint | 102 |
Semantic Scholar | Public | 74 |
DOI | Other Internet | 38 |
German National Library - URN:NBN Resolver for Germany & Switzerland | Institution | 22 |
Research Square | Preprint | 16 |
Max Planck Society - MPG.PuRe | Institution | 15 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 14 |
University of Bern - Bern Open Repository and Information System | Institution | 11 |